N-Acetyl-Phe-Octreotide
|
|
N-Acetyl-Phe-Octreotide Eigenschaften
- Siedepunkt:
- 1502.2±65.0 °C(Predicted)
- Dichte
- 1.39±0.1 g/cm3(Predicted)
- L?slichkeit
- Acetic Acid (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 12.60±0.70(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Off-White to Pale Beige
Sicherheit
N-Acetyl-Phe-Octreotide Chemische Eigenschaften,Einsatz,Produktion Methoden
N-Acetyl-Phe-Octreotide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-Acetyl-Phe-Octreotide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 34)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Moxin Chemicals | +8617320513646 |
mike@molcoo.com | China | 9563 | 58 |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 |
admin@nexconn.com | China | 10311 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19741 | 58 |
Zhejiang Hangyu API Co., Ltd | +8617531972939 |
anna@api-made.com | China | 2943 | 58 |
Henan Bao Enluo International TradeCo.,LTD | +86-17331933971 +86-17331933971 |
deasea125996@gmail.com | China | 2472 | 58 |
ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 |
sale@hdimpurity.com | China | 3413 | 58 |
Changsha MOL Changes Biotechnology Co., Ltd. | +8619375158599 |
info@molchanges.com | China | 5223 | 58 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15178 | 58 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9906 | 50 |
Hangzhou Peptide Biochem Co.,Ltd | 0571-89197072; 18668118770 |
linda@peptide-china.com | China | 248 | 56 |
- Octreotide EP Impurity-A
- Acetyl-Octreotide acetate salt
- Acetyl-Phe-octreotide
- Octreotide Acetate Impurity 1 (N-Acetyl-Phe-Octreotide)
- N-Acetyl-Phe-Octreotide
- L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
- Octreotide Acetate Impurity 1 (Octreotide EP Impurity I) (N-Acetyl-Phe-Octreotide)
- Phe(Ac)]1-Octreotide
- Octreotide EP Impurity I (N2.1-acetyloctreotide)
- Octreotide EP Impurity I Acetate
- (4R,7R,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyet
- (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-acetamido-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo
- (4R,7R,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- [6-D-allothreonine]octreotide
- (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-acetamido-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate
- (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-acetamido-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- Octreotide Acetate Impurity 1 Acetate(Octreotide EP Impurity I Acetate)(D-Phe1(Ac) Octreotide Acetate)
- 83795-61-3